Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland.
COVID-19
SARS-CoV-2
serological survey
social determinants of health
socio-economic status
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
02
2022
accepted:
29
08
2022
entrez:
10
10
2022
pubmed:
11
10
2022
medline:
12
10
2022
Statut:
epublish
Résumé
SARS-CoV-2 infection and its health consequences have disproportionally affected disadvantaged socio-economic groups globally. This study aimed to analyze the association between socio-economic conditions and having developed antibodies for-SARS-CoV-2 in a population-based sample in the canton of Geneva, Switzerland. Data was obtained from a population-based serosurvey of adults in Geneva and their household members, between November and December, 2020, toward the end of the second pandemic wave in the canton. Participants were tested for antibodies for-SARS-CoV-2. Socio-economic conditions representing different dimensions were self-reported. Mixed effects logistic regressions were conducted for each predictor to test its association with seropositive status as the main outcome. Two thousand eight hundred and eighty-nine adults completed the study questionnaire and were included in the final analysis. Retired participants and those living in suburban areas had lower odds of a seropositive result when compared to employed participants (OR: 0.42, 95% CI: 0.20-0.87) and those living in urban areas (OR: 0.67, 95% CI: 0.46-0.97), respectively. People facing financial hardship for less than a year had higher odds of a seropositive result compared to those who had never faced them (OR: 2.23, 95% CI: 1.01-4.95). Educational level, occupational position, and household income were not associated with being seropositive, nor were ethnicity or country of birth. While conventional measures of socio-economic position did not seem to be related to the risk of being infected in this sample, this study sheds lights on the importance of examining the broader social determinants of health when evaluating the differential impact of the pandemic within the population.
Sections du résumé
Background
SARS-CoV-2 infection and its health consequences have disproportionally affected disadvantaged socio-economic groups globally. This study aimed to analyze the association between socio-economic conditions and having developed antibodies for-SARS-CoV-2 in a population-based sample in the canton of Geneva, Switzerland.
Methods
Data was obtained from a population-based serosurvey of adults in Geneva and their household members, between November and December, 2020, toward the end of the second pandemic wave in the canton. Participants were tested for antibodies for-SARS-CoV-2. Socio-economic conditions representing different dimensions were self-reported. Mixed effects logistic regressions were conducted for each predictor to test its association with seropositive status as the main outcome.
Results
Two thousand eight hundred and eighty-nine adults completed the study questionnaire and were included in the final analysis. Retired participants and those living in suburban areas had lower odds of a seropositive result when compared to employed participants (OR: 0.42, 95% CI: 0.20-0.87) and those living in urban areas (OR: 0.67, 95% CI: 0.46-0.97), respectively. People facing financial hardship for less than a year had higher odds of a seropositive result compared to those who had never faced them (OR: 2.23, 95% CI: 1.01-4.95). Educational level, occupational position, and household income were not associated with being seropositive, nor were ethnicity or country of birth.
Discussion
While conventional measures of socio-economic position did not seem to be related to the risk of being infected in this sample, this study sheds lights on the importance of examining the broader social determinants of health when evaluating the differential impact of the pandemic within the population.
Identifiants
pubmed: 36211707
doi: 10.3389/fpubh.2022.874252
pmc: PMC9545483
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
874252Informations de copyright
Copyright © 2022 Santa-Ramírez, Wisniak, Pullen, Zaballa, Pennacchio, Lorthe, Dumont, Baysson, Guessous and Stringhini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet Reg Health Eur. 2022 Apr;15:100322
pubmed: 35187517
Public Health. 2020 Dec;189:129-134
pubmed: 33227595
J Popul Res (Canberra). 2021 May 29;:1-24
pubmed: 34093083
Nat Commun. 2021 Jun 8;12(1):3455
pubmed: 34103517
Front Sociol. 2020 Jun 15;5:47
pubmed: 33869454
Euro Surveill. 2022 Mar;27(13):
pubmed: 35362405
Nat Commun. 2021 Feb 10;12(1):905
pubmed: 33568663
SSM Popul Health. 2021 Mar;13:100734
pubmed: 33521228
BMC Infect Dis. 2022 Jan 9;22(1):41
pubmed: 35000580
Viruses. 2021 Jun 10;13(6):
pubmed: 34200766
PLoS One. 2021 Jun 23;16(6):e0252617
pubmed: 34161316
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Public Health Pract (Oxf). 2020 Nov;1:100013
pubmed: 34171042
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
J Epidemiol Community Health. 2020 Aug;74(8):620-623
pubmed: 32385126
BMC Res Notes. 2021 Sep 26;14(1):375
pubmed: 34565448
BMJ Open. 2022 Jan 6;12(1):e052752
pubmed: 34992110
Ann Epidemiol. 2021 Jul;59:44-49
pubmed: 33812965
Lancet Public Health. 2021 Sep;6(9):e683-e691
pubmed: 34252364
Am J Epidemiol. 1997 Jul 15;146(2):195-203
pubmed: 9230782
BMC Public Health. 2022 May 29;22(1):1067
pubmed: 35643450
JAMA. 2005 Dec 14;294(22):2879-88
pubmed: 16352796
Lancet Reg Health Eur. 2021 Sep;8:100158
pubmed: 34308411
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
JAMA Netw Open. 2020 Sep 1;3(9):e2021892
pubmed: 32975575
Dtsch Arztebl Int. 2021 Dec 3;118(48):824-831
pubmed: 35191825
J Public Health Manag Pract. 2021 Jan/Feb;27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving For:S43-S56
pubmed: 32956299
Nat Commun. 2021 Apr 9;12(1):2117
pubmed: 33837204
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Int J Equity Health. 2020 Jul 29;19(1):126
pubmed: 32727486
Int J Environ Res Public Health. 2021 Jan 30;18(3):
pubmed: 33573323
J Community Health. 2021 Aug;46(4):794-802
pubmed: 33387149
Front Public Health. 2021 Jan 27;8:626090
pubmed: 33614571
Scand J Public Health. 2022 Feb;50(1):124-135
pubmed: 34664529